VOLTALIA 4.630 € (+2,09 %)
WOLTERS KLUWER 67.500 € (+1,02 %)
Vusion 135.000 € (+1,50 %)
DASSAULT SYSTEMES 21.210 € (+1,10 %)
STELLANTIS NV 4.141 € (-1,95 %)
ING GROEP N.V. 31.770 € (+0,22 %)
ASML HOLDING 1 515.800 € (+0,56 %)
ORANGE 14.060 € (-2,33 %)
BENETEAU 5.160 € (-1,90 %)
WINAMP GROUP 0.265 € (+19,10 %)
LLAMA GROUP 0.265 € (+19,10 %)
ALSTOM 14.830 € (-2,88 %)
ABN AMRO BANK N.V. 43.500 € (+0,35 %)
EUROPLASMA 0.000 € (0,00 %)
AIRBUS 195.020 € (+0,22 %)
PHARMING GROUP 0.941 € (-2,41 %)
DNXCORP 18.200 € (-6,43 %)
CELLECTIS 1.240 € (-10,86 %)
BASIC-FIT 29.800 € (-5,70 %)
COVIVIO 46.340 € (-1,74 %)
SAFRAN 336.000 € (+1,20 %)
POSTNL 0.840 € (-2,50 %)
UNILEVER 54.460 € (-0,69 %)
SPIE 44.000 € (-1,83 %)
ETHERO 0.750 € (-18,48 %)
REMY COINTREAU 43.300 € (-1,14 %)
PROSUS 35.755 € (-4,82 %)
LEGRAND 138.150 € (-1,64 %)
HEIJMANS KON 87.200 € (+1,28 %)
MEDINCELL 23.200 € (+2,47 %)
RELX 29.320 € (+1,95 %)
LVMH 396.900 € (-1,26 %)
GENSIGHT BIOLOGICS 0.131 € (+12,93 %)
CEGEDIM 11.000 € (0,00 %)
FRANCAISE ENERGIE 20.750 € (+3,49 %)
VINCI 110.900 € (-1,25 %)
BAM GROEP KON 12.060 € (-0,17 %)
CARREFOUR 16.165 € (-1,43 %)
MAROC TELECOM 9.200 € (+0,22 %)
AXA 43.210 € (-1,59 %)
BNP PARIBAS ACT.A 100.200 € (-1,09 %)
BIOPHYTIS 0.050 € (+6,34 %)
VEOLIA ENVIRON. 31.300 € (-0,82 %)
CLARANOVA 0.599 € (-1,32 %)
THALES 238.700 € (+1,10 %)
ASR NEDERLAND 72.460 € (-0,85 %)
UMG 14.630 € (+0,58 %)
SCHNEIDER ELECTRIC 293.350 € (-0,56 %)
PEUGEOT INVEST 50.500 € (-1,75 %)
GECINA 64.650 € (-1,75 %)
CRCAM ALP.PROV.CCI 127.500 € (-0,41 %)
SAINT GOBAIN 70.640 € (-0,81 %)
ACCSYS 0.750 € (0,00 %)
GETLINK SE 18.640 € (+0,65 %)
THEON INTERNAT 31.620 € (+2,20 %)
GTT 224.800 € (+0,99 %)
TELEPERFORMANCE 73.700 € (+5,14 %)
CSG 15.990 € (+5,66 %)
ESSILORLUXOTTICA 149.950 € (+3,77 %)
EIFFAGE 105.900 € (-1,85 %) |
22/09/2026 18:00
H1 2026 results: improvement in margins and continued execution of the disposal strategySeptember 22, 2026 at 18h
In the first half of 2026, Prodways Group continued to implement its strategy, focused on divesting the Systems division's businesses and improving profitability. The Group reached a first major milestone during the period with the sale of the Software business for €35 million. At the same time, the current EBITDA margin improved significantly across the reported scope. At the date on which the interim financial statements were approved, the process to sell the Materials business, operated by the subsidiary Deltamed, had progressed sufficiently to meet the criteria for classification as a discontinued operation under IFRS 5. The financial statements published for the first half of 2026 therefore present the Materials and Software businesses as discontinued operations, including in the historical comparative data. The Systems division included in continuing operations now consists solely of the Printers business. On this new scope, Prodways Group generated revenue of €15.9 million in the first half of 2026, up slightly by 1% compared with the restated first half of 2025. Current EBITDA amounted to €0.6 million, representing a margin of 3.6%, an improvement of nearly 7 points. H1 2026 consolidated income statement
The financial statements presented above were approved by the Company's Board of Directors, which met on September 22, 2026. Since the Company's transfer to Euronext Growth, the interim financial statements are not subject to a review by the Statutory Auditors. The full financial statements are available in the appendix to this press release.
Revenue and income from ordinary activities by division[3]
Revenue: stable activity in the first half of 2026 In the first half of 2026, Prodways Group generated revenue of €15.9 million, up slightly by 1% compared with the restated first half of 2025. This change reflects growth in the Systems division, which now consists solely of the Printers business, while revenue in the Products division remained stable. Systems division – printers activity The Printers business generated revenue of €1.7 million in the first half of 2026, up 19% compared with the first half of 2025. This growth was mainly driven by MovingLight printers for ceramic applications. Following several years of development work with major aerospace companies, certain applications are gradually moving from qualification and development phases into serial production. This momentum has continued since the end of the period, with an order for around ten MovingLight printers signed with a US aerospace industrial player, for a total value of a few million euros. Deliveries will take place throughout 2027. Products division The Products division generated revenue of €14.2 million in the first half of 2026, stable compared with the first half of 2025. The Digital Manufacturing business improved progressively over the period. In France, the increase in order intake observed over several quarters translated into revenue growth of nearly 10% in the second quarter. This momentum was partly offset by lower activity in Germany. In a weakened competitive environment, Prodways is beginning to benefit from market share gains as a result of its commercial efforts and financial discipline. In Audiology, following a slight decline in the first quarter, revenue stabilized in the second quarter. Commercial initiatives helped broaden the customer base, although performance continued to be affected by internal execution issues. The consolidation of sites into more suitable premises should help resolve some of these difficulties.
A marked improvement in the current EBITDA margin Prodways Group generated current EBITDA of €0.6 million in the first half of 2026, compared with -€0.5 million in the restated first half of 2025. The current EBITDA margin therefore reached 3.6%, an improvement of nearly 7 points. This increase reflects improved profitability in both divisions and lower corporate costs. The Systems division significantly reduced its losses, with current EBITDA of -€0.1 million, compared with -€0.5 million in the restated first half of 2025. The current EBITDA margin improved by 24 points to -9%. This improvement was driven by higher volumes in the Printers business, resulting in much better absorption of fixed costs. The Products division generated current EBITDA of €1.4 million, up 21% despite stable revenue. The current EBITDA margin reached 10%, compared with 8% in the first half of 2025, reflecting the impact of the measures implemented to improve the profitability of the division's businesses. Lastly, corporate costs decreased by nearly €0.5 million to -€0.7 million, compared with -€1.2 million in the restated first half of 2025. This change made a significant contribution to the improvement in Group profitability.
Operating income of -€1.0 million After depreciation, amortization and provisions, income from ordinary activities amounted to -€1.0 million in the first half of 2026, an improvement of nearly €1.0 million compared with the restated first half of 2025. The Products division returned to positive income from ordinary activities of €0.1 million, while the Systems division reduced its loss slightly to -€0.5 million. As other items of operating income were not material, operating income also amounted to -€1.0 million, compared with -€2.0 million in the restated first half of 2025.
Net income of €15.1 million, driven by the sale of the Software business The financial result represented an expense of €0.2 million, compared with €0.3 million in the restated first half of 2025. After tax, net income from continuing operations amounted to -€1.3 million. Net income from discontinued operations amounted to €16.3 million, including a €17.4 million capital gain on the sale of the Software business, completed in May 2026. As a result, consolidated net income amounted to €15.1 million.
A strengthened financial position Continuing operations generated cash flow from operations of €0.2 million in the first half of 2026, compared with -€0.6 million in the restated first half of 2025. Working capital requirements represented a cash outflow of €0.5 million, broadly stable year on year. As a result, net cash flow generated by operating activities was -€0.3 million. Capital expenditure remained under control at €1.0 million over the period. In addition, the sale of the Software business generated net cash proceeds of €31.5 million, bringing cash from continuing operations to €34.4 million at June 30, 2026. Excluding IFRS 16 lease liabilities, Prodways Group therefore had net cash of €25.1 million at June 30, 2026, compared with net debt of €4.4 million at December 31, 2025.
€20 million returned to shareholders through the public share buyback offer Following the sale of the Software business, Prodways Group launched a public share buyback offer for a total amount of €20 million, with the aim of returning a significant portion of the disposal proceeds to shareholders. The offer, which ran from July 7 to July 28, 2026 inclusive, provided for the repurchase of up to 18,181,818 shares at a price of €1.10 per share. As the number of shares tendered exceeded the maximum number sought, Prodways Group repurchased 18,181,818 shares. These shares were subsequently cancelled as part of a capital reduction completed on August 6, 2026.
Prospects for the disposal of the Materials business Prodways Group is continuing to implement its strategy to divest the Systems division's businesses. The Materials business now generates limited synergies with the Group's other activities, particularly following the refocusing of the Printers business on MovingLight printers for ceramic applications. At the date on which the interim financial statements were approved, the process to sell the Materials business, operated by the subsidiary Deltamed, had progressed sufficiently to meet the criteria for classification as a discontinued operation under IFRS 5. The assets and liabilities of this business are therefore presented as held for sale in the financial statements at June 30, 2026. The Group will keep the market informed of the next steps in the disposal process.
Outlook and objectives for 2026 Based on the scope of continuing operations presented in the financial statements, Prodways Group confirms its objective of maintaining stable or slightly higher revenue in 2026 and improving the current EBITDA margin. The first-half performance, marked by 1% revenue growth and an improvement of nearly 7 points in the current EBITDA margin, reinforces the Group's confidence in achieving these objectives.
About Prodways Group Prodways Group is a specialist in industrial and professional 3D printing with a unique positioning as an integrated European player. The Group has developed across the entire 3D printing value chain through high-value-added industrial solutions. Prodways Group offers a range of 3D printing systems and premium composite materials (SYSTEMS division). The Group also manufactures and markets on-demand parts, prototypes and small series in plastic and metal using 3D printing (PRODUCTS division). Prodways Group addresses a large number of sectors, particularly in the medical field. Prodways Group is listed on Euronext Growth (FR0012613610 - ALPWG). More information about https://www.prodways-group.com Follow us and live the latest news from Prodways Group on Twitter and LinkedIn! @Prodways
Contacts
INVESTOR CONTACTS
Hugo Soussan Investor Relations Tel: +33 (0)1 44 77 94 86 / h.soussan@prodways.com
Anne-Pauline Petureaux Shareholder relations Tel: +33 (0)1 53 67 36 72 / apetrureaux@actus.fr
PRESS CONTACTS Manon Clairet Financial press relations Tel: +33 (0)1 53 67 36 73 / mclairet@actus.fr
Appendices Definition of alternative performance indicators
Consolidated financial statements Classification of Deltamed under IFRS 5 At the date on which the 2026 interim financial statements were approved, the process to sell Deltamed was considered sufficiently advanced to meet the criteria for classification under IFRS 5. DeltaMed is therefore presented as a discontinued operation, with the assets and liabilities being reclassified as "assets and liabilities held for sale". Net income, as well as the cash flows generated by this activity, are presented on separate lines of the income statement and the cash flow statement, with retrospective restatement of comparative data for the 2025 financial year.
Consolidated income statement
Cash flow statement
Consolidated balance sheet - assets
Consolidated balance sheet - liabilities
[1] Income statement restated following the classification of the Materials and Software activities as discontinued operations in accordance with IFRS 5. [2] See the Glossary in the appendix for the definition of alternative performance indicators [3] The sum of the aggregates of the two divisions must be adjusted for intra-group eliminations and corporate costs, representing an expense of €0.7 million in H1 2026 income from ordinary activities, to reconcile with the consolidated result presented above. Source : Webdisclosure.com |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière